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human health
Hanna Fjeldheim Dale, Lise Madsen, and Gu¨len Arslan Lied
Emerging evidence from studies evaluating the effect of lean fish consumption in
humans suggests that proteins from fish have several beneficial metabolic effects.
Rest, or waste, material from the fishing industry contains high-quality proteins,
and utilization of this material offers novel possibilities for the development of
protein-containing products that might be beneficial for human consumption. Fish-
derived peptides containing bioactive amino acid sequences suggested to benefi-
cially influence pathways involved in body composition, hypertension, lipid profile,
and regulation of glucose metabolism are of particular interest, although the results
of published studies are conflicting. This review aims to summarize current knowl-
edge from animal studies and clinical interventions in humans evaluating the
effects of lean fish, fish proteins, and fish-derived peptides on outcomes related to
metabolic health. Fish proteins have a high content of taurine, and animal trials
suggest that taurine mediates some of the beneficial effects observed thus far, al-
though the mechanisms by which fish peptides exert their action are not yet eluci-
dated. At this time, the literature is inconsistent, and there is insufficient mechanistic
evidence to support a beneficial effect of fish-derived peptides on metabolic health.
INTRODUCTION
The beneficial effects of fish consumption have tradi-
tionally been attributed to the marine-derived omega-3
(n-3) polyunsaturated fatty acids (PUFAs) present in
fish, but emerging evidence from studies evaluating the
effects of lean fish consumption suggests that the pro-
teins from fish may also have several beneficial meta-
bolic effects.1–4 It is generally assumed that the
consumption of fish has a protective effect against dif-
ferent diseases related to lifestyle. In particular, the rela-
tionship between cardiovascular disease and fish
consumption has received much attention. The positive
association between fish intake and decreased risk of
stroke and coronary heart disease is well documented
by meta-analyses of observational studies.5,6 The results
of studies investigating the possible associations be-
tween fish consumption and development of metabolic
syndrome and type 2 diabetes mellitus (T2DM) are,
however, inconsistent.7–12 The beneficial effects of diets
rich in fish have, to a large extent, been attributed to the
marine n-3 PUFAs.13,14 However, studies reporting
beneficial health effects of lean fish in both animals and
humans suggest that substances other than the marine
n-3 PUFAs, such as fish protein, may beneficially
influence metabolic health by improving insulin
sensitivity, glucose metabolism, lipid status, and body
composition.12,15,16
While the beneficial health effect of an adequate
amount of protein in the diet is well established, the
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specific effect of bioactive peptides—beyond the supply
of nutrients—has recently drawn increasing interest.
Preliminary data suggest that bioactive peptides derived
from marine resources may have a beneficial effect on
several health outcomes related to metabolic health.17–20
This increased interest and early research have provided
a platform from which to examine the potential for bet-
ter utilization of rest material from the fishing industry.
Waste material with a high content of high-quality pro-
tein may be valuable for human consumption, and fish-
derived protein hydrolysates with bioactive peptides are
hypothesized to be particularly beneficial.21
This review aims to summarize current knowledge
from animal studies and intervention studies in humans
evaluating the effects of lean fish, fish proteins, and
fish-derived peptides on metabolic pathways involved
in outcomes related to metabolic health, including glu-
cose metabolism, lipid status, hypertension, and body
weight and composition.
FISH PROTEINS AND BIOACTIVE PEPTIDES
Fish and marine resources, including fish processing
by-products, are excellent sources of high-quality pro-
tein, and an increasing amount of evidence points to-
ward beneficial effects of these marine proteins on
metabolic health.1,4,22 The nutritional value of a food
protein depends on several factors, including primary
structure of the protein, susceptibility of the protein to
enzymatic digestion, chemical changes of the protein
during processing, amino acid composition of the pro-
tein, and content of essential amino acids in the protein.
A high-quality protein source has a high relative con-
tent of essential amino acids.23 In general, proteins
from fish contain all the essential amino acids and have
a particularly high content of the essential amino acids
lysine and leucine. Of the nonessential amino acids, as-
partic acid, glutamic acid, and alanine are usually pre-
sent in very high amounts in marine protein sources,
along with the amino acid–derived organic acid tau-
rine.24 The digestibility of most seafood proteins
exceeds 90%, and thus the essential amino acids in ma-
rine proteins are highly exploitable.23
The fishing industries around the world generate a
tremendous amount of protein-containing rest mate-
rial, which is normally discarded but, when properly
processed, can be used for human consumption. The
utilization of marine by-products, such as waste and
cuttings from which protein hydrolysates can be
extracted, is both environmentally friendly and cost ef-
fective, with positive consequences for both the industry
and human health.17 Following ingestion of whole pro-
tein, bioactive peptides are formed naturally in the gut,
either by enzymatic degradation (hydrolysis) or
microbial fermentation. They can also be consumed as
a nutritional supplement that contains already-
hydrolyzed protein. The biological activity of a peptide
derived from food is highly dependent on the structural
properties of the peptide, including the molecular mass
and characteristics of the amino acids present in the
peptide, whereas the biological activity of a peptide de-
rived from a protein hydrolysate is dependent on sev-
eral factors, including the enzymes utilized in the
hydrolysis process, the pH and temperature during hy-
drolysis, the duration of hydrolysis, and the enzyme-to-
substrate ratio applied.25 Bioactive peptides tend to be
present as di- and tripeptides with low molecular mass
and contain 2 to 20 amino acid residues. The bioactivity
of peptides is linked to the presence of different amino
acid sequences. A bioactive peptide may produce a local
effect in the gastrointestinal tract or a systemic effect af-
ter being absorbed in the gut and entering the circula-
tion.26 Some of the amino acid sequences present in
fish proteins are proposed to have a unique potential to
beneficially modulate different metabolic pathways and
thereby contribute to the prevention of disease
(Figure 1). Different amino acid sequences present in
fish-derived peptides are suggested to be capable of re-
ducing hypertension by inhibiting angiotensin-1 con-
verting enzyme, beneficially altering blood glucose
metabolism through mechanisms such as inhibition of
dipeptidylpeptidase-4, and altering the gut microbiota
by contributing to increased conjugation of bile acids.21
ANIMAL STUDIES INVESTIGATING THE EFFECTS OF
FISH PROTEIN
Studies with intact fish protein
Several studies in rats and mice have investigated the
metabolic effect of intact fish protein in the diet, com-
paring the effect of proteins from fish with that of ca-
sein or proteins from terrestrial animals.
Cod protein in combination with fish oil lowered
the rate of hepatic triacylglycerol secretion in rats when
compared with casein in a 28-day dietary intervention
study, thereby beneficially altering lipid metabolism.27
A study in rats that compared the metabolic effect of a
4-week high-fat diet that included protein from cod,
soy, or casein found that cod and soy proteins, when
compared with casein, improved fasting glucose toler-
ance and peripheral insulin sensitivity. Postprandial
samples taken after test meals revealed that the rats fed
cod or soy protein had lower plasma insulin concentra-
tions, possibly due to decreased release of pancreatic in-
sulin and increased removal of insulin by the liver.28
Furthermore, the high-fat diets with soy and casein in-
duced severe insulin resistance, while the high-fat diet
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with cod protein fully prevented the development of in-
sulin resistance. The effect of the cod protein was linked
to a direct action of amino acids on insulin-stimulated
glucose uptake in skeletal muscle cells.15
The same research group later investigated the cel-
lular mechanisms behind this action and reported a
beneficial effect of cod protein on insulin sensitivity,
which was attributed to maintenance of the insulin
receptor substrate-1-associated phosphatidylinositol 3-
kinase (PI3K) pathway, which in turn led to improved
translocation of glucose transporter 4 to the T-tubules
in the cells.29 This pathway was significantly downregu-
lated, leading to reduced insulin sensitivity when the
rats were fed high-fat diets with soy or casein. Together,
these results indicate that dietary cod protein, or
components of the cod protein, may act as a natural
insulin-sensitizing agent that can possibly prevent insu-
lin resistance linked to obesity by normalizing the insu-
lin activation of the PI3K/Akt pathway and improving
translocation of glucose transporter 4 present on the
cell surface.29 Importantly, it should be noted that both
studies are based on values from a hyperinsulinemic-
euglycemic clamp and tracer injection in rats; therefore,
the proposed mechanisms might not be translatable to
humans, and the results must be interpreted with
caution.
A number of animal trials indicate that high-fat
diets containing lean seafood are less obesogenic than
high fat-diets containing meat from terrestrial animals.
Mice fed a Western diet high in fat and sucrose and
Figure 1 Potential effects of bioactive fish-derived peptides. Bioactive peptides can be formed naturally by ingestion of whole protein
and subsequent microbial fermentation or degradation of enzymes in the gut, or they can be consumed as a nutritional supplement with al-
ready-hydrolyzed protein. They tend to have 2 to 20 amino acid residues, and their bioactive effect is linked to the presence of different
amino acid sequences (simplified example shown in figure). Some of the peptide sequences present in fish proteins have been proposed to
have a unique potential to beneficially modulate different metabolic pathways and thereby contribute to the prevention of disease. Different
amino acid sequences present in fish-derived peptides have been proposed to be capable of reducing hypertension by inhibiting ACE, alter-
ing blood glucose metabolism beneficially through different mechanisms such as inhibition of DPP-4, and contributing to increased conjuga-
tion of bile acids. Abbreviations: ACE, angiotensin-converting enzyme; Cys, cysteine; DPP-4, dipeptidylpeptidase-4; Ile, isoleucine; Lys, lysine;
Tyr, tyrosine; Val, valine.
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containing a mixture of lean seafood (ling, rose fish,
cod, wolf fish) and muscle from Canadian scallop were
reported to gain less adipose tissue mass than mice fed
a Western diet containing a mixture of skinless chicken
breast, pork tenderloin, and beef sirloin.30 A diet con-
taining a mixture of protein from cod and scallop was
reported to reduce fat mass and improve glucose toler-
ance when compared with isoenergetic diets containing
either chicken or casein, respectively, in mice fed a
high-fat diet for 6 weeks.31 The feed efficiency values
were lower in the mice fed cod/scallop and casein than
in the mice fed chicken. In addition the mice fed cod/
scallop and casein had reduced adipose tissue mass in
compared with mice fed chicken. In addition, the mice
fed chicken had both elevated concentrations of triacyl-
glycerol in the liver and elevated fasting plasma choles-
terol concentrations compared with the other groups.
These findings show that protein from different food
sources modulates the energy balance differently in
mice. Compared with other protein sources, the cod
protein mix was more likely to prevent diet-induced
obesity and improve glucose tolerance.31 It should be
noted that this study investigated protein from a combi-
nation of cod and scallop, and not protein from cod in
particular. The effect of other sources of fish proteins
has been studied in rats fed a high-fat, high-sucrose
diet.32 Proteins were provided from casein, salmon, her-
ring, mackerel, or bonito. Despite equal energy intake,
the group fed salmon protein had a significantly lower
weight gain, reduced visceral adiposity, and improved
insulin sensitivity compared with the other groups.32
Collectively, these data suggest that different sources of
fish protein may exert different metabolic effects.
A recent study investigated whether changing the
protein source from pork to cod in a regular Western
diet would alter the endocannabinoid tone in mice and
thereby reduce both the development of obesity and the
accumulation of fat in the liver.33 The results showed
that the cod-fed mice had significantly lower concentra-
tions of 2 major circulating endocannabinoids, a lower
increase in adipose tissue, and a lower content of he-
patic lipids than the pork-fed mice. Protein from sea-
food has a high content of taurine, and a negative
correlation between adiposity and intake of taurine and
glycine has been demonstrated in mice fed chicken,
cod, crab, or scallop in high-fat, high-sucrose diets.34 In
line with this, both taurine35 and glycine36,37 are
reported to attenuate obesity development in rodents,
and increased intakes of glycine, taurine, arginine, and
lysine, all found in fish protein, are associated with anti-
inflammatory effects in rats.38
Together, these findings suggest an overall benefi-
cial metabolic effect of protein sources from lean
seafood.
Studies with fish protein hydrolysates
Several animal studies have investigated the specific ef-
fect of fish protein hydrolysates from different kinds of
fish and marine protein sources. Most studies have
compared the effect of a fish protein hydrolysate with
casein and/or soy.
A fat-free protein hydrolysate from salmon, when
compared with casein, has been reported to possibly have
a cardioprotective effect in rats by reducing plasma total
cholesterol, increasing high-density lipoprotein cholesterol
(HDL-C), and lowering acyl-coenzyme A:cholesterol acyl-
transferase (ACAT) activity in the liver.39 However, the
same beneficial effects seen in the rats fed fish protein hy-
drolysate were observed in the rats fed soy protein, and
thus the effect of the fish protein was not unique. Both the
soy protein diet and the fish protein hydrolysate diet had
low ratios of both methionine to glycine and lysine to ar-
ginine compared with the casein diet, and this was pro-
posed to contribute to the reduction in cholesterol levels.
A study in rats that compared a salmon protein hy-
drolysate with casein found that the rats fed the salmon
protein hydrolysate became resistant to high-fat-diet–
induced obesity, had reduced postprandial plasma glu-
cose and triacylglycerol levels, and lower triacylglycerol
levels in the liver compared with the rats fed casein.40
The plasma bile acid concentrations were elevated in
the rats fed the salmon protein hydrolysate, a finding
associated with the induction of genes involved in en-
ergy metabolism. These genes were found to stimulate
an increase in energy expenditure and a decrease in
body mass. Overall, the findings indicated the salmon
protein hydrolysate diet, when compared with the ca-
sein diet, to have a beneficial effect on several metabolic
markers.40 A similar effect in rats has been reported for
a fish protein hydrolysate from saithe when compared
with proteins from soy and casein.41 In this study, the
fish hydrolysate, which had a high content of taurine
and glycine, was shown to elevate fasting levels of bile
acids and reduce visceral adipose tissue mass in rats. In
both experiments, the casein or soy control diet was
supplemented with 3% L-cysteine to avoid depletion of
sulfur-containing amino acids. These findings on lipid
metabolism are supported by a later study indicating
that a fish protein hydrolysate from salmon, also rich in
taurine and glycine, beneficially altered the fatty acid
composition in liver and adipose tissue and increased
plasma carnitine levels in a mouse model of chronic in-
flammation.42 The mice were fed a high-fat diet con-
taining either 20% casein (control) or 15% fish protein
hydrolysate and 5% casein.
A recent study investigated the effect of a diet com-
prised of 75% protein from casein/whey and 25% pro-
tein from fish protein hydrolysates derived from either
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herring or salmon.16 The rats fed the herring-
containing diet presented lower levels of serum HDL-C
and low-density lipoprotein cholesterol (LDL-C) as well
as higher levels of serum triacylglycerol than the rats fed
the casein/whey diet, whereas the rats fed the salmon-
containing diet gained more weight and had better
postprandial blood glucose regulation than the rats fed
the casein/whey diet. These findings imply a negative
effect of herring on lipid status. The ratios of lysine to
arginine and methionine to glycine were lower in the 2
fish diets than in the casein/whey diet, whereas taurine
was present only in the fish diets. The authors linked
the observed effects to the bioactive motives present in
the different fish protein hydrolysates.16 The same 2 fish
protein hydrolysates were later reported to contain sev-
eral peptide sequences with possible angiotensin-1 con-
verting enzyme (ACE)-inhibiting activities and to
beneficially alter the urine concentrations of glucose,
protein, and cystatin C.43
Discussion of results from animal studies
Overall, the findings from current animal studies are
not clear regarding the specific metabolic effect of either
fish protein or fish protein hydrolysates. Several studies
report beneficial metabolic effects of diets containing
protein from fish, but results about whether fish pro-
teins are more beneficial than other sources of protein
are inconsistent. The use of different control diets
makes the comparison of results challenging.
Likewise, the results of studies investigating the ef-
fect of different types of fish protein hydrolysates are
highly inconsistent. As in the studies that examined fish
protein, the use of different protein sources in control
diets makes a valid comparison of the effects of fish pro-
tein hydrolysates difficult. Several studies have sug-
gested that fish protein hydrolysates contain bioactive
peptides that may have beneficial metabolic effects on
health outcomes related to lifestyle diseases, but the lack
of identified mechanisms weakens these findings.
Although several different peptide sequences have been
identified in marine-derived proteins and are suggested
to beneficially modulate metabolic pathways, this is a
new area of research that requires further investigation
in humans before the potential of these peptides as an
ingredient in nutritional supplements or nutraceutical
products can be determined.21
In many of the animal studies in this review, casein
in the form of whole protein was used in the control
diet. Comparing the effect of fish protein with casein
may not be straightforward, in part because of the low
content of sulfur-containing fatty acids in casein. To
avoid depletion of sulfur amino acids that would also
lead to taurine deficiency, commercially available diets
comprising 20% protein in form of casein are supple-
mented with 0.3% methionine or cysteine to meet the
requirements of the American Institute of Nutrition.44
However, dairy proteins, such as casein and whey, have
a high content of branched-chain amino acids that may
possess antiobesogenic properties45,46 and reduce insu-
lin signaling.47 In addition, the metabolic response to
casein is well investigated, and casein is known to be a
slowly digested protein capable of lowering the rate of
gastric emptying.48,49 This could arguably cause prob-
lems related to the rate of digestion when casein is com-
pared with other sources of protein. In particular, when
the effects of high-protein diets are examined, casein as
a protein source does not seem to be representative.33,50
The pattern of digestion of casein is unique, and casein
has been shown to affect gut hormones involved in glu-
cose metabolism by generating an insulinotropic effect
and affecting the absorption rate of different amino
acids.51 Thus, the use of casein as a control protein can
arguably be a limitation. It can be questioned whether
the observed beneficial metabolic effects of fish proteins
in the studies using casein as control are attributable to
a truly beneficial effect of fish proteins or simply to a
correction of a negative metabolic effect of casein.
Rodent studies in which different protein sources are
compared with casein should therefore be interpreted
with caution.
Furthermore, the form of the casein protein used,
ie, intact protein vs hydrolyzed peptides, has been
shown to be decisive for the metabolic effect when ca-
sein is investigated in animal models.52,53 Hydrolyzed
casein, when compared with intact casein, has been
found to induce physiological changes that result in
decreases in body mass, adipose tissue mass, and plasma
insulin concentrations.53 Hydrolyzed casein has also
been shown to facilitate beneficial changes in carbohy-
drate and amino acid metabolism associated with re-
duced glucose concentrations and lipid levels in mice.52
Overall, these findings suggest that hydrolyzed pro-
teins in general, and not just a fish protein per se, may
be particularly effective in beneficially altering metabo-
lism, and thus studies comparing hydrolyzed fish pro-
tein with whole casein must acknowledge this when
results are interpreted. In addition, in the animal stud-
ies included in the current review, the different fish pro-
tein hydrolysates investigated contain crude protein
extracts with different compositions of amino acids as
well as different amounts of ash, maltodextrin, and
moisture. Thus, it is possible that an effect could
be caused by the composition of other nutrient or non-
nutrient components of the test material. Overall,
the current animal studies have several limiting
issues, and thus the results should be interpreted with
caution.
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INTERVENTION STUDIES INVESTIGATING THE EFFECTS
OF FISH PROTEIN IN HUMANS
Several studies in humans have investigated the health
effect of an intervention with lean fish, but the type of
intervention, the study participants, and the
outcome measures differ greatly between studies
(Table 1)1–4,54–62. Most intervention studies have com-
pared lean fish with fatty fish or a non-seafood diet con-
taining equal amounts of protein from lean meat, eggs,
chicken, and dairy products.
Some studies have reported a beneficial effect of
lean fish consumption on lipid status,1,2 whereas others
have reported no effect or a negative effect on lipid con-
centrations.55–57,59 Two studies have reported a benefi-
cial effect of lean fish on glucose metabolism,3,4 whereas
1 study reported no effect.61 One study has reported
lean fish to reduce blood pressure in patients with car-
diovascular disease,62 but the same effect was not seen
in a group of overweight or obese individuals.54
Body weight
Only 1 study has evaluated the effect of cod protein,
consumed as part of a weight loss diet, on weight man-
agement.54 The study included 126 overweight or obese
individuals and evaluated the effects of different
amounts of cod (150 g, 3 or 5 times per week, compared
with a non-seafood diet) in an energy-restricted weight
loss diet. Total energy expenditure and a 30% reduction
in caloric intake were calculated individually for each
participant. All 3 diets had an identical macronutrient
composition and a similar distribution of energy (30%E
from lipids, 50%E from carbohydrates, and 20%E from
protein). The authors found a dose-dependent relation-
ship between cod consumption and weight loss, with
the diet containing the most cod showing the most fa-
vorable effect. Change in cardiovascular risk factors
were similar between the 3 groups, but when all groups
were merged, the prevalence of metabolic syndrome
dropped from 29% to 21%.54 Notably, the study imple-
mented a 2-day weighed food record only at baseline
and during the last week of the intervention, and the
lack of controlling for diet and caloric intake during the
intervention can arguably be considered a limitation of
the design. Controlling for diet could possibly have
revealed differences in energy intake that may have
explained the weight loss beyond the effect of cod
protein.
Lipid status
Several studies of the effect of lean fish protein on lipid
metabolism have been conducted, but results have been
inconsistent. A large proportion of these compared the
effect of lean fish vs fatty fish. Both salmon and cod
were found to lower triacylglycerol levels equally when
compared with an isocaloric potato diet in a 15-day
parallel-group intervention performed in 30 healthy
individuals.2 The 3 study diets differed in the amount of
n-3 fatty acids provided, with the potato diet containing
144mg/d, the cod diet 154.3mg/d, and the salmon diet
5412.1mg/d. The study found both lean and fatty fish
to improve lipid status by reducing the ratio of 18:1n-9
to 18:0 in plasma.2 This finding is not consistent with
the results of a 4-week parallel-group intervention con-
ducted in 38 healthy individuals who were given 750 g
of cod, salmon, or lean meat per week. Importantly, no
differences in energy or macronutrient intake were ob-
served between the groups, either at baseline or after
the 4-week intervention. In this study, salmon, but not
cod, significantly reduced triacylglycerol concentrations
and increased fasting levels of HDL-C in serum when
compared with lean meat. The salmon intervention,
compared with the cod intervention, increased HDL-
C.59 This finding is supported by a study in 33 patients
with coronary heart disease.58 Consumption of lean fish
or fatty fish was compared with consumption of lean
meat as a control in an 8-week intervention. Fatty fish,
but not lean fish, increased the particle size of HDL-C,
which might be beneficial in patients with coronary
heart disease.58 The energy intake during the interven-
tion did not change from the baseline measures in any
of the groups, but, as expected, the intake of n-3 fatty
acids increased in the group that ate fatty fish.
Studies that do not compare lean and fatty fish but
only investigate the effects of lean fish vs a non-seafood
diet report inconsistent findings. Several intervention
studies report either a negative effect or no effect of a
lean fish intervention. Two 4-week crossover trials in
post- and premenopausal women evaluated the effect of
a diet containing proteins from lean white fish com-
pared with the effect of an isocaloric diet containing
proteins from milk, eggs, pork, veal, and beef.55,56 The
trial performed in 15 postmenopausal women reported
the diet containing lean white fish to induce higher con-
centrations of total plasma cholesterol and HDL-C than
the non-seafood diet, thereby negatively affecting the
lipid profile.55 The 2 test diets contained similar
amounts of energy and an equal distribution of energy
provided from protein (19%E), lipids (29%E), and car-
bohydrates (52%E). Cholesterol content was similar in
both diets. The weight of the participants did not
change during the intervention.
The crossover trial in 14 premenopausal women
performed some years later supported this finding and
reported no significant improvements in lipid profiles
assessed after the lean fish diet.56 The lean fish diet and
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the non-seafood diet contained equal amounts of en-
ergy as well as an equal distribution of energy from pro-
tein (20%E), lipids (30%E), and carbohydrates (50%E).
The lean fish group was given a daily calcium and
vitaminD supplement because dairy products had been
eliminated from the diet, and all participants main-
tained a stable weight throughout the intervention.
Another study comparing a non-seafood diet with a
lean fish diet in 11 normolipidemic men reported the
lean fish diet to induce higher concentrations of plasma
cholesterol and HDL-C. This effect was associated with
variations in plasma sex hormone status and lipoprotein
lipase activity.57 The 2 test diets were isocaloric and had
a similar nutrient distribution (18%E from protein,
52%E from carbohydrates, 32%E from lipids) and a
similar ratio of polyunsaturated to saturated fatty acids.
In contrast, a randomized crossover trial in 20
healthy individuals that compared the effect of protein
from lean seafood with that of non-seafood protein
reported lean seafood protein to significantly reduce
fasting and postprandial serum triacylglycerol and pre-
vent an elevated ratio of total cholesterol to HDL-C in
fasting and postprandial serum samples.1 The lean sea-
food diet consisted of cod, pollock, saithe, and scallops,
whereas the non-seafood diet included lean beef,
chicken filet, turkey filet, pork, eggs, milk, and dairy
products. The experimental diets were isocaloric, with a
similar distribution of nutrients (19%E from protein,
29%E from lipids, and 52%E from carbohydrates).
Participants who consumed the non-seafood diet were
supplemented with cod liver oil to ensure both groups
had a similar intake of eicosapentaenoic acid and doco-
sahexaenoic acid. Each group was followed for 4weeks,
separated by a 5-week washout period. The same
authors later reported that the lean seafood diet benefi-
cially altered the fasting and postprandial ratio of tria-
cylglycerol to HDL-C.3
Glucose metabolism
A 4-week crossover study in 19 overweight or obese
individuals compared the effect of a cod protein diet
with the effect of a diet containing similar amounts of
protein from lean beef, pork, veal, eggs, milk, and dairy
products. The diets differed only in the source of pro-
tein and provided equal amounts of carbohydrates and
lipids, including n-3 PUFAs. The cod protein diet sig-
nificantly improved insulin sensitivity and reduced the
levels of circulating C-reactive protein compared with
the mixed-protein diet.4,60 This is consistent with the
results of a 4-week crossover study in 20 healthy indi-
viduals in whom a lean seafood diet did not alter serum
glucose or insulin concentrations but reduced postpran-
dial C-peptide and lactate concentrations when
compared with a non-seafood diet.3 The 2 experimental
diets contained equal amounts of energy (29%E lipids,
52%E carbohydrates, 19%E protein), with lean seafood
or non-seafood sources contributing 60%E of total pro-
tein intake. They concluded that the lean seafood diet
beneficially altered lipid status and influenced glucose
metabolism in a manner that may beneficially affect the
long-term development of insulin resistance, T2DM,
and cardiovascular disease.1,3
The same group that reported a beneficial effect of
salmon intake on lipid status also investigated the effect
of 750 g of cod or salmon per week compared with non-
seafood proteins on glucose metabolism in 68 over-
weight or obese individuals for 8weeks.61 Intake of en-
ergy and macronutrients did not change within the
groups during the intervention. Salmon, but not cod,
significantly improved postprandial glucose regulation
and increased insulin C-peptide concentrations to a
lesser degree than cod or control.61 These findings sug-
gest that intake of fatty fish, but not lean fish, benefi-
cially alters glucose and lipid metabolism and, hence,
reduces the risk for insulin resistance, T2DM, and car-
diovascular disease.
In conclusion, beneficial effects of cod protein on
glucose metabolism and insulin sensitivity have been
reported in several studies, but the findings are
inconsistent.
Hypertension
A few studies have investigated the specific effect of cod
protein consumption on hypertension. The previously
described study investigating the effect of cod consump-
tion in a weight loss diet reported no effect of different
amounts of cod consumption on blood pressure.54 A
study examining the effect of lean fish or fatty fish com-
pared with lean meat as control in patients with coro-
nary heart disease found lean fish (consumed 4 times
per week) to reduce blood pressure and, hence, to be
beneficial in this group.62 The participants were all
given similar instructions by a dietitian about following
a diet recommended for patients with coronary heart
disease, with group-specific instructions to include 100
to 150 g of fish (fatty or lean) in 4 meals per week. The
control group was instructed to consume lean meat and
less than 1 fish meal per week.
INTERVENTION STUDIES WITH FISH PEPTIDE
SUPPLEMENTS IN HUMANS
Several recent studies have investigated the effect of
supplements with marine peptides (protein hydroly-
sates) on metabolic health in humans, with overall
promising findings.
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Two recent studies, both of which used an 8-week
intervention protocol, have reported on the metabolic
effect of a cod protein hydrolysate in overweight or
obese individuals.19,22 Vikøren et al19 conducted a study
in 34 individuals and were the first to investigate the
specific effect of a cod protein hydrolysate on metabolic
markers. Participants were divided in 2 groups who re-
ceived either placebo tablets or fish-derived peptides.
The fish peptide group was given 3 g of fish protein sup-
plement per day for the first 4 weeks and 6 g per day for
the last 4 weeks. Eight weeks of supplementation led to
lower fasting and postprandial glucose levels, a benefi-
cially altered postprandial insulin C-peptide concentra-
tion, reduced body fat, increased lean body mass, and
reduced LDL-C. No effect on blood pressure was found,
but overall, a beneficial effect on several metabolic
markers was observed.19 A study by the same research
group did not observe the same significant beneficial ef-
fect on insulin regulation but found that 6 g of cod pep-
tide supplementation per day significantly lowered
serum concentrations of nonesterified fatty acids.22
One study has investigated the effect of a peptide
from a sardine muscle hydrolysate on blood pressure in
a randomized controlled trial of 29 individuals. The
authors reported the specific valyl-tyrosine peptide
from sardine to have a significant antihypertensive ef-
fect in individuals with mild hypertension by inhibiting
ACE.63
A study investigating the effect of 2 different doses
of supplementation with a fish protein hydrolysate from
blue whiting in 120 overweight individuals reported
both doses to improve body composition and decrease
body weight as well as increase levels of cholecystokinin
and glucagon-like peptide 1 in serum.18 The trial lasted
for 90 days, and participants were allocated into 3 arms,
receiving either 1.4 g or 2.8 g of fish protein hydrolysate
per day or 1.4 g of whey protein isolate as placebo, in
addition to receiving an individually adjusted mildly
hypocaloric diet (300 kcal/d). Both doses of fish pro-
tein hydrolysate were found to significantly reduce
body weight, body mass index, and fat mass as well as
waist, thigh, and hip circumference when compared
with placebo. The effect was equal for both doses, indi-
cating a plateau effect starting at 1.4 g.
Recently a randomized, double-blind crossover
trial investigating the effect of a cod protein hydrolysate
on postprandial glucose metabolism was performed in
41 healthy, middle-aged individuals.20 The results sup-
port the findings of Vikøren et al,19 who reported bene-
ficial postprandial alterations in glucose values after
supplementation with a fish protein hydrolysate. A sin-
gle dose of 20mg of cod protein hydrolysate per kilo-
gram of body weight, when compared with casein as
control, was found to significantly reduce postprandial
insulin concentrations without affecting blood glucose
levels in healthy individuals.20 The effect observed in
this study should be further investigated in patients
with impaired glucose metabolism.
Discussion of results from human studies
Overall, the results from studies evaluating the meta-
bolic effect of fish proteins show highly inconsistent
results. It must be noted that the studies performed in
obese and overweight individuals, in contrast to studies
performed in healthy individuals, pose a highly different
starting point with regard to metabolic health, making
comparison of the results difficult. Furthermore, both
the type of intervention and the amount of lean fish
provided in the different studies vary greatly. The stud-
ies evaluating the effect of lean fish in comparison with
fatty fish may have been influenced by n-3 fatty acids,
which are present in much higher concentrations in
salmon than in cod. A major consideration when evalu-
ating the effect of a dietary intervention based on fish
consumption is to definitively determine whether the
observed effect is due to the intervention or simply to
the removal of other foods with a nonbeneficial health
effect, such as red meat. Studies investigating the effect
of different fish protein hydrolysates are more consis-
tent in their findings and report an overall promising
metabolic effect of supplements containing low concen-
trations of peptides from fish. The fact that these studies
do not alter the nutritional composition of the partici-
pants’ diets, but instead simply add a peptide on top of
the normal diet, is arguably a strength compared with
the intervention studies that used whole fish. Although
current results are inconsistent overall, most of the re-
search reveals several beneficial health effects of lean
fish consumption.
POSSIBLE LINKS BETWEEN FISH PROTEINS
AND GUT MICROBIOTA
Obesity and metabolic diseases such as T2DM are asso-
ciated with a dysbiotic gut microbiota, seen as a devia-
tion of the organization of microbes that would
promote optimal metabolic homeostasis.64 So far, little
is known about the ability of different protein sources
to modulate the gut microbiota. Some recent animal
studies have found that a diet containing proteins from
lean seafood tends to be less obesogenic than a regular
Western diet containing proteins from meat such as
chicken, pork, or beef.30,65 Comparison of the gut
microbiome of mice fed 2 different Western diets (with
lean seafood vs lean meat) revealed significant differen-
ces in the abundance of microbial genes.30
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Marine protein sources tend to have moderate to
high content of the branched-chain amino acids valine,
leucine, and isoleucine. These amino acids participate
in several metabolic pathways and are present in high
concentrations shown to counteract obesity develop-
ment in mice fed a high-fat diet.66 Furthermore, supple-
mentation with branched-chain amino acids is
demonstrated to beneficially alter the composition of
the gut microbiota by increasing the abundance of spe-
cies associated with protection against obesity develop-
ment.67 However, compared with proteins from fish,
the milk proteins casein and whey have an even higher
content of branched-chain amino acids, and casein has
been shown to be more efficient than proteins from cod
in preventing weight gain and an increase in adipose
tissue in mice.65
Fish proteins, the gut microbiota, and lipid status
A randomized controlled crossover trial previously
reporting on glucose and lipid metabolism in response
to lean seafood consumption in 20 healthy human indi-
viduals1,3 recently also reported on the effect of lean
seafood and non-seafood consumption on fecal metab-
olites and the gut microbiome.68 The authors observed
a twofold increase in fecal trimethylamine excretion af-
ter the lean seafood intervention. Moreover, the ratio
between total cholesterol and HDL-C and the circulat-
ing levels of triacylglycerol and trimethylamine N-oxide
(a metabolite associated with increased risk of cardio-
vascular disease) were each associated with specific gut
bacteria. The non-seafood diet caused a decreased
abundance of Clostridium cluster IV as well as an in-
creased ratio of Firmicutes to Bacteroides. Overall, the
authors concluded that the presence of seafood in the
diet affects the gut microbiome composition and activ-
ity, which in turn seems to affect circulating concentra-
tions of trimethylamine N-oxide and, hence, the risk for
cardiovascular disease.68
Taurine, bile acid metabolism, and the gut microbiota
Marine protein sources tend to have a higher level of
taurine, an amino acid–derived organic compound
shown to prevent diet-induced weight gain and im-
prove insulin sensitivity in rats, than other animal pro-
tein sources.69,70 A fish protein hydrolysate diet with a
high content of taurine was found to elevate plasma bile
acids and reduce visceral adipose tissue mass in rats.41
Interestingly, the same research group later reported
that the nutritional regulation of bile acid metabolism
was associated with beneficial alterations in several
markers involved in the development of metabolic syn-
drome.40 Primary bile acids are synthesized from
cholesterol in the liver before they are conjugated with
taurine or glycine and further metabolized into second-
ary bile acids by the gut microbiota. These bile acids
serve as ligands for nuclear receptors involved in the de-
velopment of obesity and metabolic disorders.71,72 For
instance, it has been reported that patients with T2DM
have elevated levels of taurine-conjugated bile acids,73
and a high ratio of 12a-hydroxy to non-12a-hydroxy
bile acid has been associated with lower insulin
sensitivity.74
Treatment of naive T2DM patients with Acarbose,
an alpha-glycosidase inhibitor used as an alternative to
metformin in several Asian countries, increases the ra-
tio between primary and secondary bile acids and
plasma levels of unconjugated bile acids, possibly by
changing the relative abundance of microbial genes in-
volved in bile acid metabolism.75 In that study, multiple
correlations between changes in plasma bile acids and
clinical parameters, including body weight, homeostasis
model assessment–insulin resistance, and lipid profile
were found. Of note, patients with a higher baseline
abundance of Bacteroides organisms in their gut micro-
biota and lower levels of secondary bile acids exhibited
better therapeutic responses to Acarbose treatment, in-
cluding reduced body mass index, improved insulin re-
sistance status, and improved lipid profile, suggesting
that baseline metagenome signatures may be used to
stratify patients with T2DM prior to treatment. The
role of the gut microbiota in regulating the metabolism
of secondary bile acids poses novel questions about
whether different marine proteins, which have different
amino acid compositions, may be able to prevent or
treat obesity and impaired glucose metabolism.
FUTURE RESEARCH DIRECTIONS
Although the overall beneficial health effects of fish
consumption are well documented, more knowledge is
needed on the specific effects of proteins from fish, par-
ticularly how fish proteins affect the metabolic pathways
involved in the development of disease and impaired
metabolic health. Increasing interest in the relationship
between metabolic health and the gut microbiota may
lead future research in exciting novel directions. Few
studies have investigated the specific relationship be-
tween consumption of fish proteins and alterations in
the gut microbiota. Although some single studies sug-
gest that proteins from fish may benefit the gut micro-
biota composition and, hence, influence body weight,
lipid status, and bile acid metabolism, no conclusions
can be drawn from the existing literature. Future re-
search should investigate whether fish proteins can in-
fluence the gut microbiota composition and, hence,
affect the development of disease, and should determine
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whether dietary supplements with bioactive marine
peptides affect the gut microbiota and improve health.
Taurine contained within marine compounds has been
highlighted as a possible modulator of bile acid metabo-
lism and, thus, improved metabolic health. As bile acid
metabolism is dependent on the gut microbiota compo-
sition, the relationship between bile acid metabolism
and specific taurine-containing proteins or supple-
ments, along with implications for the gut microbiota
and metabolic health, should be investigated in more
detail in future human studies. In conclusion, future re-
search should investigate the specific metabolic health
effects of nutritional supplements containing marine
peptides with possibly bioactive sequences.
CONCLUSION
Increasing evidence suggests that components other
than the long-chain n-3 fatty acids from fish may have a
beneficial health effect, and recent literature points to-
ward proteins and peptides from fish as possibly being
able to influence metabolic health. However, results from
both experimental studies in animals and clinical studies
in humans evaluating the effect of fish proteins and pep-
tides are highly inconsistent, and no clear mechanistic
effects are known thus far. Although novel results indi-
cate a beneficial effect of marine peptides and dietary
supplements containing fish protein hydrolysates on
pathways involved in metabolic health, there is a lack of
knowledge on the specific mechanisms for these actions.
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